0


Basic View | Expanded View
 Showing 1-20 of 44 Articles
Viewpoint  FREE
Jerome P. Kassirer, MD
While our national leaders agonize about the threats in the Middle East from missiles, bombs, and automatic weapons that might fall into ...
Arch Intern Med. doi:10.1001/jamainternmed.2013.4026
Research Letters  FREE
Peter Doshi, PhD; Tom Jefferson, MD
Includes: Supplemental Content
On November 30, 2010, the regulatory agency for medications in Europe, the European Medicines Agency (EMA), announced a policy on access to ...
Topics: , , , , , , , , , , ,
Arch Intern Med. doi:10.1001/jamainternmed.2013.3838
Commentary  FREE
Robert Steinbrook, MD
As of January 2014, the European Medicines Agency (EMA) will publish clinical trial data for the medications it considers for approval.1 After ...
Topics: , , , , , , , , , , , , , , , , , , , , , , , , ,
Arch Intern Med. doi:10.1001/jamainternmed.2013.3842
Original Investigation 
David S. Weinberg, MD, MSc; Eileen Keenan, MA, CCRP; Karen Ruth, MS; Karthik Devarajan, PhD; Michelle Rodoletz, PhD; Eric J. Bieber, MD
BackgroundBackground New methods to enhance colorectal cancer (CRC) screening rates are needed. The web offers novel possibilities to educate patients and to ...
Arch Intern Med. doi:10.1001/2013.jamainternmed.1017
Research Letters 
Jane J. Kim, PhD; Monisha Sharma, MS; Jesse Ortendahl, MS
Includes: Supplemental Content
Despite the success of cytology-based (Papanicolaou) screening in the United States, over 12 000 women develop and 4000 women die from cervical ...
Topics: , , , ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.1034
Research Letters 
Benjamin K. I. Helfand, MSc; Kenneth J. Mukamal, MD, MPH
Healthcare workers (HCWs) represent an important group in which to study individual health behaviors, both because they are more knowledgeable than others ...
Topics: ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.1039
Research Letters 
Lisa Benz Scott, PhD; Shannon Gravely, PhD; Thomas R. Sexton, PhD; Sabrina Brzostek, PhD; David L. Brown, MD
Globally, cardiovascular diseases are the leading causes of morbidity and mortality.1 Secondary prevention measures, such as outpatient cardiac rehabilitation (OCR), effectively reduce ...
Arch Intern Med. doi:10.1001/2013.jamainternmed.1042
Original Investigation 
Gabriel N. Mannis, MD; Julia E. Fehniger, BA; Jennifer S. Creasman, MSPH; Vanessa L. Jacoby, MD, MAS; Mary S. Beattie, MD, MAS
BackgroundBackground For women at potentially increased risk for ovarian cancer, data regarding screening and risk reduction are limited. Previous studies have reported ...
Topics: ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.962
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Furthermore, it is preventable with routine screening ...
Arch Intern Med. doi:10.1001/jamainternmed.2013.2527
Genetic history of BRCA1/2 mutations identifies women who are at high risk for breast and ovarian cancer and who may benefit from ...
Topics: , , ,
Arch Intern Med. doi:10.1001/jamainternmed.2013.2729
Perspectives  FREE
Sunita Puri, MD, MS
Mr C, a 78-year-old man with a history of Zollinger-Ellison syndrome with metastatic gastrinoma requiring subtotal gastrectomy with gastrojejunostomy, multiple past gastrointestinal ...
Topics: , , , , , , ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.826
Original Investigation 
George Howard, DrPH; Daniel T. Lackland, DrPH; Dawn O. Kleindorfer, MD; Brett M. Kissela, MD; Claudia S. Moy, PhD; Suzanne E. Judd, PhD; Monika M. Safford, MD; Mary Cushman, MD, MSc; Stephen P. Glasser, MD; Virginia J. Howard, PhD
BackgroundBackground Between the ages 45 and 65 years, incident stroke is 2 to 3 times more common in blacks than in whites, ...
Topics: , , , ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.857
The 10-year health promotion and disease prevention goals set forth by the US Department of Health and Human Services in Healthy People ...
Topics: , , ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.863
Original Investigation 
Alyce S. Adams, PhD; Connie Uratsu, RN; Wendy Dyer, MS; David Magid, MD, MPH; Patrick O’Connor, MD, MA, MPH; Arne Beck, PhD; Melissa Butler, PharmD, MPH, PhD; P. Michael Ho, MD, PhD; Julie A. Schmittdiel, PhD
BackgroundBackground The purpose of this study was to identify potential health system solutions to suboptimal use of antihypertensive therapy in a diverse ...
Topics: ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.955
Original Investigation  FREE
Jun Ma, MD, PhD; Veronica Yank, MD; Lan Xiao, PhD; Philip W. Lavori, PhD; Sandra R. Wilson, PhD; Lisa G. Rosas, PhD; Randall S. Stafford, MD, PhD
Includes: Supplemental Content
BackgroundBackground The Diabetes Prevention Program (DPP) lifestyle intervention reduced the incidence of type 2 diabetes mellitus (DM) among high-risk adults by 58%, ...
Topics: , , , ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.987
Original Investigation  FREE
Bonnie Spring, PhD; Jennifer M. Duncan, PsyD; E. Amy Janke, PhD; Andrea T. Kozak, PhD; H. Gene McFadden, BA; Andrew DeMott, BA; Alex Pictor, BA; Leonard H. Epstein, PhD; Juned Siddique, PhD; Christine A. Pellegrini, PhD; Joanna Buscemi, PhD; Donald Hedeker, PhD
BackgroundBackground A challenge in intensive obesity treatment is making care scalable. Little is known about whether the outcome of physician-directed weight loss ...
Topics: ,
Arch Intern Med. doi:10.1001/jamainternmed.2013.1221
A staggering 68% of US adults are either overweight or obese.1 Current direct medical costs associated with treating obesity-related illness are roughly ...
Topics: ,
Arch Intern Med. doi:10.1001/jamainternmed.2013.1232
Research Letters 
PhilipJ. Gregory, PharmD
The stimulant DMAA, also known as 1,3-dimethylamylamine, has been the subject of much controversy.1 In the United States, it is currently marketed ...
Arch Intern Med. doi:10.1001/2013.jamainternmed.724
Original Investigation 
Dimitri M. Drekonja, MD, MS; Thomas S. Rector, PhD; Andrea Cutting, MA; James R. Johnson, MD
Includes: Supplemental Content
BackgroundBackground Lengthier antimicrobial therapy is associated with increased costs, antimicrobial resistance, and adverse drug events. Therefore, establishing minimum effective antimicrobial treatment durations ...
Topics: , , ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.829
Research Letters 
Dimitri M. Drekonja, MD, MS; Breanna Zarmbinski, BA; James R. Johnson, MD
The value of preoperative urine screening is unproven, except before urologic procedures, in which detection and treatment of asymptomatic bacteriuria is beneficial.1 ...
Topics: ,
Arch Intern Med. doi:10.1001/2013.jamainternmed.834

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)